CM
Caption Management Portfolio holdings
AUM
$1.72B
1-Year Est. Return
7.75%
1 Year Est. Return
+7.75%
AUM
$1.09B
AUM Growth
-$1.1B
(-50%)
Holding
1,115
Top Buys
| 1 | +$21.2M | |
| 2 | +$20.1M | |
| 3 | +$16.5M | |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$16.4M |
| 5 |
Kellanova
K
|
+$14.9M |
Top Sells
| 1 | +$394M | |
| 2 | +$314M | |
| 3 | +$255M | |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$130M |
| 5 |
Cisco
CSCO
|
+$61.7M |
Sector Composition
| 1 | Healthcare | 25.54% |
| 2 | Consumer Discretionary | 20.68% |
| 3 | Technology | 13.39% |
| 4 | Financials | 8.7% |
| 5 | Communication Services | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tesla
TSLA
$1.49T
| $95.3M | 1.05% |
300,000
+4,000
|
|
||
|
2
Alphabet (Google) Class C
GOOG
$3.79T
| $40.2M | 0.44% |
226,397
-307,028
|
|
||
3
Soleno Therapeutics
SLNO
$2.66B
| $22.1M | 0.24% |
263,287
-31,713
|
|
||
4
Insmed
INSM
$41.6B
| $21.2M | 0.24% |
+210,928
|
|
||
|
SKX
5
DELISTED
Skechers
SKX
| $20.1M | 0.22% |
+317,932
|
|
||
6
Gilead Sciences
GILD
$153B
| $16.5M | 0.18% |
+148,600
|
|
||
|
7
Regeneron Pharmaceuticals
REGN
$78.5B
| $16.4M | 0.18% |
+31,200
|
|
||
|
8
Kellanova
K
$29B
| $15M | 0.17% |
188,281
+187,145
|
|
||
9
iShares MSCI India ETF
INDA
$9.41B
| $14.2M | 0.16% |
+255,280
|
|
||
10
Galicia Financial Group
GGAL
$7.86B
| $13.9M | 0.15% |
275,708
+28,206
|
|
||
11
Mastercard
MA
$506B
| $13.3M | 0.15% |
+23,700
|
|
||
12
Cidara Therapeutics
CDTX
$6.92B
| $13.1M | 0.14% |
+268,000
|
|
||
13
Starbucks
SBUX
$96.4B
| $12M | 0.13% |
+131,000
|
|
||
14
Visa
V
$666B
| $11.4M | 0.13% |
32,000
|
|
||
15
ARK Innovation ETF
ARKK
$7.55B
| $10.9M | 0.12% |
154,700
-7,400
|
|
||
16
Janux Therapeutics
JANX
$924M
| $10.6M | 0.12% |
457,012
+412,569
|
|
||
17
Boot Barn
BOOT
$6.34B
| $10.3M | 0.11% |
68,000
+45,500
|
|
||
18
Arvinas
ARVN
$807M
| $9.88M | 0.11% |
1,343,029
+1,279,329
|
|
||
|
CBL
19
CBL Properties
CBL
$1.13B
| $8.81M | 0.1% |
347,059
-97,551
|
|
||
20
Vistra
VST
$59.2B
| $8.72M | 0.1% |
45,000
+34,300
|
|
||
21
Ultragenyx Pharmaceutical
RARE
$3.49B
| $8.64M | 0.1% |
237,500
+58,672
|
|
||
22
Henry Schein
HSIC
$8.98B
| $8.62M | 0.1% |
118,000
+111,138
|
|
||
23
Nice
NICE
$6.73B
| $8.52M | 0.09% |
+50,416
|
|
||
24
Core Scientific Inc Tranche 1 Warrants
CORZW
$1B
| $8.15M | 0.09% |
751,544
+251,544
|
|
||
25
Natera
NTRA
$32.2B
| $7.6M | 0.08% |
+45,000
|
|